Company Filing History:
Years Active: 2024
Title: Alicia Hurtado Martinez: Pioneering Antitumor Immunity Innovations
Introduction
Alicia Hurtado Martinez is an innovative inventor based in New York, NY, who has made significant contributions to the field of cancer treatment through her groundbreaking patents. With a focus on enhancing antitumor immunity, her work has the potential to revolutionize how we approach cancer therapies.
Latest Patents
Alicia holds two notable patents. The first patent involves the induction and enhancement of antitumor immunity using virus vectors that express multiple epitopes of tumor-associated antigens and immune checkpoint inhibitors. This patent provides polynucleotides and viral vectors, such as alphavirus or Sindbis viral vectors, which encode multiple epitopes of at least one tumor-associated antigen. Each epitope is separated by a processing or enzyme cleavage site, allowing for effective immune response generation. The second patent focuses on Sindbis virus vectors that express immune checkpoint proteins. This innovation aims to treat mammalian subjects with cancer by administering viral vectors that encode immune checkpoint proteins, resulting in significant tumor growth reduction and increased survivability.
Career Highlights
Alicia is affiliated with New York University, where she continues her research and development in the field of immunotherapy. Her work is characterized by a commitment to advancing cancer treatment methodologies and improving patient outcomes.
Collaborations
Alicia collaborates with esteemed colleagues, including Daniel Meruelo and Christine Pampeno, who contribute to her research endeavors and help drive innovation in cancer therapies.
Conclusion
Alicia Hurtado Martinez is a remarkable inventor whose work in antitumor immunity is paving the way for new cancer treatment strategies. Her patents reflect a deep understanding of immunology and a dedication to improving the lives of those affected by cancer.